Mediclin AG buy kostojunior
Start price
10.01.21
/
60%
€4.36
Target price
10.01.22
€6.00
Performance (%)
-15.14%
End price
11.01.22
€3.70
Summary
This prediction ended on 11.01.22 with a price of €3.70. The price of Mediclin AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.14%. kostojunior has 60% into this prediction This prediction was marked as speculative and is excluded from kostojunior's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Mediclin AG | 0.000% | 0.000% | -7.843% | -36.771% |
iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
According to kostojunior what are the pros and cons of Mediclin AG for the foreseeable future?
Pros
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
Very high dividend yield expected
Small Risks for its business
Well known brand
Cons
Comments by kostojunior for this prediction
In the thread Mediclin AG diskutieren
Buy mit Kursziel 5,0
Kursziel geändert auf 6,0
In the thread Trading Mediclin AG
Die von kostojunior gewählte maximale Laufzeit wurde überschritten
Stopped prediction by kostojunior for Mediclin AG
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
13.11.22
13.11.22
€3.00
13.11.23
13.11.23
-0.60%
26.11.22
26.11.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
07.03.22
07.03.22
-
07.03.23
07.03.23
0.60%
19.03.22
19.03.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€5.40
05.06.16
05.06.16
€7.00
05.12.16
05.12.16
5.89%
05.12.16
05.12.16
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€4.00
14.05.12
14.05.12
€4.90
14.11.12
14.11.12
-0.15%
14.11.12
14.11.12
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€3.98
23.11.10
23.11.10
€4.50
23.05.11
23.05.11
5.66%
23.05.11
23.05.11
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€3.10
03.03.10
03.03.10
€4.99
19.04.10
19.04.10
17.42%
19.04.10
19.04.10
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model